Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP232479.RAudqzRHg_lMSdBqj1eROjHtWjEiTJck9VG6QaC1jBLis130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP232479.RAudqzRHg_lMSdBqj1eROjHtWjEiTJck9VG6QaC1jBLis130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP232479.RAudqzRHg_lMSdBqj1eROjHtWjEiTJck9VG6QaC1jBLis130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP232479.RAudqzRHg_lMSdBqj1eROjHtWjEiTJck9VG6QaC1jBLis130_provenance.
- NP232479.RAudqzRHg_lMSdBqj1eROjHtWjEiTJck9VG6QaC1jBLis130_assertion description "[Inhibitors of lipogenic signaling, including those that inhibit the AKT pathway, might be useful as therapeutics for patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232479.RAudqzRHg_lMSdBqj1eROjHtWjEiTJck9VG6QaC1jBLis130_provenance.
- NP232479.RAudqzRHg_lMSdBqj1eROjHtWjEiTJck9VG6QaC1jBLis130_assertion evidence source_evidence_literature NP232479.RAudqzRHg_lMSdBqj1eROjHtWjEiTJck9VG6QaC1jBLis130_provenance.
- NP232479.RAudqzRHg_lMSdBqj1eROjHtWjEiTJck9VG6QaC1jBLis130_assertion SIO_000772 21147110 NP232479.RAudqzRHg_lMSdBqj1eROjHtWjEiTJck9VG6QaC1jBLis130_provenance.
- NP232479.RAudqzRHg_lMSdBqj1eROjHtWjEiTJck9VG6QaC1jBLis130_assertion wasDerivedFrom befree-20150227 NP232479.RAudqzRHg_lMSdBqj1eROjHtWjEiTJck9VG6QaC1jBLis130_provenance.
- NP232479.RAudqzRHg_lMSdBqj1eROjHtWjEiTJck9VG6QaC1jBLis130_assertion wasGeneratedBy ECO_0000203 NP232479.RAudqzRHg_lMSdBqj1eROjHtWjEiTJck9VG6QaC1jBLis130_provenance.
- befree-20150227 importedOn "2015-02-27" NP232479.RAudqzRHg_lMSdBqj1eROjHtWjEiTJck9VG6QaC1jBLis130_provenance.